Literature DB >> 19701973

Barrier-focused intervention to increase colonoscopy attendance among nonadherent high-risk populations.

Wen Meng1, Xi-Wen Bi, Xiao-Yin Bai, Hua-Feng Pan, Shan-Rong Cai, Qi Zhao, Su-Zhan Zhang.   

Abstract

AIM: To increase attendance for colonoscopy among nonadherent high-risk individuals for colorectal cancer (CRC) screening in China.
METHODS: During the first 12 mo without intervention, only 428 of the 2398 high-risk subjects attended a scheduled colonoscopy examination. The 1970 subjects who did not attend for CRC screening were enrolled in the present study. Prior barrier investigation was performed to ascertain the reasons for nonadherence. A barrier-focused intervention program was then established and implemented among eligible nonadherent subjects by telephone interviews and on-site consultations. The completion rates of colonoscopy during the first 12 mo without intervention and the second 12 mo with intervention were compared. Variations in the effect of the intervention on some high-risk factors and barrier characteristics were analyzed using logistic regression.
RESULTS: 540 subjects who were not eligible were excluded from the study. The colonoscopy attendance rate was 23.04% (428/1858) during the first 12 mo without intervention, and 37.69% (539/1430) during the second 12 mo with intervention (P < 0.001). Logistic regression analysis showed that the intervention was more effective among subjects with only objective barriers (OR: 34.590, 95% CI: 23.204-51.563) or subjects with some specific high-risk characteristics: first-degree relatives diagnosed with CRC (OR: 1.778, 95% CI: 1.010-3.131), personal history of intestinal polyps (OR: 3.815, 95% CI: 1.994-7.300) and positive result for immunochemical fecal occult blood testing (OR: 2.718, 95% CI: 1.479-4.996).
CONCLUSION: The barrier-focused telephone or on-site consultation intervention appears to be a feasible means to improve colonoscopy attendance among nonadherent high-risk subjects for CRC screening in China.

Entities:  

Mesh:

Year:  2009        PMID: 19701973      PMCID: PMC2731255          DOI: 10.3748/wjg.15.3920

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis.

Authors:  F D Reid; P M Mercer; M harrison; T Bates
Journal:  Scand J Gastroenterol       Date:  1996-02       Impact factor: 2.423

2.  Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial.

Authors:  Thomas D Denberg; John M Coombes; Tim E Byers; Alfred C Marcus; Lawrence E Feinberg; John F Steiner; Dennis J Ahnen
Journal:  Ann Intern Med       Date:  2006-12-19       Impact factor: 25.391

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial.

Authors:  Allen J Dietrich; Jonathan N Tobin; Andrea Cassells; Christina M Robinson; Mary Ann Greene; Carol Hill Sox; Michael L Beach; Katherine N DuHamel; Richard G Younge
Journal:  Ann Intern Med       Date:  2006-04-18       Impact factor: 25.391

5.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

Review 6.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

7.  A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives.

Authors:  Susan M Rawl; Victoria L Champion; Linda L Scott; Honghong Zhou; Patrick Monahan; Yan Ding; Patrick Loehrer; Celette Sugg Skinner
Journal:  Patient Educ Couns       Date:  2008-03-04

8.  Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.

Authors:  A F van Rijn; L G M van Rossum; M Deutekom; R J F Laheij; P Fockens; P M M Bossuyt; E Dekker; J B M J Jansen
Journal:  J Public Health (Oxf)       Date:  2008-08-20       Impact factor: 2.341

9.  Tailored navigation in colorectal cancer screening.

Authors:  Ronald E Myers; Terry Hyslop; Randa Sifri; Heather Bittner-Fagan; Nora C Katurakes; James Cocroft; Melissa Dicarlo; Thomas Wolf
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

10.  Barriers to colorectal cancer screening in community health centers: a qualitative study.

Authors:  Karen E Lasser; John Z Ayanian; Robert H Fletcher; Mary-Jo DelVecchio Good
Journal:  BMC Fam Pract       Date:  2008-02-27       Impact factor: 2.497

View more
  9 in total

1.  Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.

Authors:  Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

Review 2.  How to improve colon cancer screening rates.

Authors:  Luiz Ronaldo Alberti; Diego Paim Carvalho Garcia; Debora Lucciola Coelho; David Correa Alves De Lima; Andy Petroianu
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

3.  Impact of a Multifaceted Intervention on Promoting Adherence to Screening Colonoscopy Among Persons in HIV Primary Care: A Pilot Study.

Authors:  Pansy Ferron; Shihab S Asfour; Lisa R Metsch; Michael H Antoni; Allan E Rodriguez; Robert Duncan; Sheila M Findlay
Journal:  Clin Transl Sci       Date:  2015-05-21       Impact factor: 4.689

4.  Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.

Authors:  Wen Meng; Hong-Hong Zhu; Ze-Feng Xu; Shan-Rong Cai; Qi Dong; Qiang-Rong Pan; Shu Zheng; Su-Zhan Zhang
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

5.  Performance value of high risk factors in colorectal cancer screening in China.

Authors:  Wen Meng; Shan-Rong Cai; Lun Zhou; Qi Dong; Shu Zheng; Su-Zhan Zhang
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

6.  Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract.

Authors:  Gary V Martinez; Suryakiran Navath; Kamini Sewda; Venkataramanarao Rao; Parastou Foroutan; Ramesh Alleti; Valerie E Moberg; Ali M Ahad; Domenico Coppola; Mark C Lloyd; Robert J Gillies; David L Morse; Eugene A Mash
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

7.  Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.

Authors:  Celestin Hategeka; Prince Adu; Allissa Desloge; Robert Marten; Ruitai Shao; Maoyi Tian; Ting Wei; Margaret E Kruk
Journal:  PLoS Med       Date:  2022-07-25       Impact factor: 11.613

8.  Cost-effectiveness of colorectal cancer screening protocols in urban Chinese populations.

Authors:  Weidong Huang; Guoxiang Liu; Xin Zhang; Wenqi Fu; Shu Zheng; Qunhong Wu; Chaojie Liu; Yang Liu; Shanrong Cai; Yanqin Huang
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

9.  Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.

Authors:  Jianping Wang; Side Liu; Hui Wang; Lei Zheng; Changchun Zhou; Guoxin Li; Rongkang Huang; Huaiming Wang; Chujun Li; Xinjuan Fan; Xinhui Fu; Xinying Wang; Hongliang Guo; Jie Guan; Yanlai Sun; Xilin Song; Zengjun Li; Dianbin Mu; Jujie Sun; Xianglin Liu; Yan Qi; Feng Niu; Chunhua Chen; Xiaolin Wu; Xianshu Wang; Xianrang Song; Hongzhi Zou
Journal:  Clin Epigenetics       Date:  2020-10-30       Impact factor: 6.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.